CD44V6在非小细胞肺癌组织中的表达及其意义

 目的　探讨CD44v6在非小细胞肺癌（NSCLC）组织中的表达及其对预后判定的意义。方法　应用免疫组织化学方法对1995年12月至2002年9月62例手术NSCLC组织标本进行CD44v6的检测。结果　62例NSCLC中CD44v6阳性表达38例，阳性率为61.3 ％，CD44v6阳性表达率与淋巴结转移及 3年生存率有密切关系，不同肿瘤分化程度、病理分型及TNM分期间差异无统计学意义。结论　NSCLC患者CD44v6阳性表达与肿瘤淋巴结转移及患者生存率关系密切，可以作为临床评估肿瘤转移及判断预后的指标。

Expression and significance of CD44v6 in non-small-cell lung cancer

Objective To study the expression of CD44v6 in non-small-celt lung cancer and significance in judgement of prognosis.Methods CD44v6 expression in non-small-cell lung cancer tissues was detected in 62 patients with lung cancer operation in 1995-2002 year by immunohistohemistry method.Results The positive rate of CD44v6 in NSCLC was 61.3%,which was related to lymph node metastasis and 3-year survival rate in patients,but not to cell differentiation,pathological sort and TNM stage.Conclusion The positive expression of CD44v6 may be involved in lymph node metastasis and survival rate in NSCLC patients.It might be useful to evaluate the possibility of cancer metastasis and prognosis.